RULE 13D-1(C) FILING

Company

Verrica Pharmaceuticals Inc.

Filed

June 25, 2018

Accession Number

0000947871-18-000525

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →